Search details
1.
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(3): 339-351, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30795951
2.
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
Lancet Oncol
; 17(9): 1230-9, 2016 Sep.
Article
in English
| MEDLINE | ID: mdl-27501767
3.
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Lancet
; 386(9992): 433-43, 2015 Aug 01.
Article
in English
| MEDLINE | ID: mdl-26040499
4.
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.
Support Care Cancer
; 23(6): 1741-8, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25433440
5.
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.
Lancet Oncol
; 14(2): 125-33, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23312888
6.
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Breast Care (Basel)
; 17(2): 137-145, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35707180
7.
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies.
Cancer Med
; 11(18): 3387-3396, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35315594
8.
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO).
Eur J Cancer
; 166: 126-133, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35290913
9.
Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial.
BMC Cancer
; 11: 373, 2011 Aug 24.
Article
in English
| MEDLINE | ID: mdl-21864402
10.
Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe.
Onkologie
; 34(5): 233-8, 2011.
Article
in English
| MEDLINE | ID: mdl-21577028
11.
Sentinel node biopsy after primary chemotherapy in breast cancer: a note of caution from results of ABCSG-14.
Breast J
; 17(3): 230-8, 2011.
Article
in English
| MEDLINE | ID: mdl-21450019
12.
Tissue distribution of epirubicin after severe extravasation in humans.
Cancer Chemother Pharmacol
; 88(2): 203-209, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33907881
13.
microRNA expression profiles distinguish colorectal cancer patients in two regions of Austria.
Int J Clin Pharmacol Ther
; 52(1): 85-6, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24216143
14.
Exosomal microRNA transfer varies with specific microRNAs functional in colorectal cancer and cellular differentiation.
Int J Clin Pharmacol Ther
; 52(1): 87-8, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24219968
15.
NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model.
Int J Clin Pharmacol Ther
; 51(1): 35-7, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23259994
16.
Harnessing the potential of therapeutic agents to safeguard bone health in prostate cancer.
Prostate Cancer Prostatic Dis
; 21(4): 461-472, 2018 11.
Article
in English
| MEDLINE | ID: mdl-29988100
17.
Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro.
Cancer Lett
; 257(1): 73-8, 2007 Nov 08.
Article
in English
| MEDLINE | ID: mdl-17686575
18.
Subclinical involvement of the liver is associated with prognosis in treatment naïve cancer patients.
Oncotarget
; 8(46): 81250-81260, 2017 Oct 06.
Article
in English
| MEDLINE | ID: mdl-29113384
19.
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna.
ESMO Open
; 1(4): e000066, 2016.
Article
in English
| MEDLINE | ID: mdl-27843624
20.
The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status.
J Cancer Res Clin Oncol
; 131(7): 420-8, 2005 Jul.
Article
in English
| MEDLINE | ID: mdl-15864644